Dulaglutide, a groundbreaking glucagon-like peptide-1 (GLP-1) receptor agonist, holds a crucial role in managing type 2 diabetes. The increasing requirement for this medication has spurred the growth of US-based manufacturing facilities dedicated to producing dulaglutide. These facilities implement cutting-edge technologies and stringent quality co